Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Rose-Nussbaumer, MD
Stanford University
Study Director - Thuy Doan, MD, PhD
University of California San Fransicso
Study Director - Ying Han, MD, PhD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prism Eye Institute, University of Toronto
Toronto, Canada
Recruiting
- University of California San Francisco
San Francisco, California, United States
Recruiting - Diablo Eye Associates
Walnut Creek, California, United States
Recruiting - Bascom Palmer Eye Institute
Miami, Florida, United States
Recruiting - Wilmer Eye Institute, Johns Hopkins University
Baltimore, Maryland, United States
Recruiting - Massachusetts Eye and Ear
Boston, Massachusetts, United States
Recruiting - University of Buffalo/state University of New York
Buffalo, New York, United States
Recruiting - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jul 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2027
- Last update posted
- 27 Jun 2025
- Registered enrollment
- 226
- Registry id
- NCT05924477
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.